Source disclosure: February 10, 2026
Matsuya R&D Co.,Ltd [7317.T]
TOKYO — Matsuya R&D Co., Ltd. (Code: 7317, Tokyo Growth) announced on February 10, 2026, that it has recorded a special loss of 124 million yen related to an open tender offer from Omron Healthcare Co., Ltd. for its shares and subscription rights during the third quarter ending December 31, 2025.
The company disclosed that as part of this tender offer, various advisory fees and legal expenses totaling 124 million yen were recognized as extraordinary losses. Furthermore, the company anticipates additional costs associated with the tender process, which could bring the total special loss to approximately 270 million yen by the end of the fiscal year.
For more information regarding the tender offer, shareholders can refer to the announcement made on December 15, 2025, titled "Statement of Support and Recommendation for Shareholders to Participate in Open Tender Offer."
Regarding the impact on performance, the 124 million yen in special losses is already reflected in the interim report released today. The company stated that these expenses will have a minor effect on consolidated earnings forecasts.
AI-translated content. 🟢 Confidence: High See terms • Original filing